One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood.v128.22.4202.4202
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Dec 2, 2016 |
 Citations: 4 |
Affiliation: Hôpital Claude Huriez, University of Lille, AZ Groeninge, Centre Hospitalier Universitaire de Bordeaux, Institute Paoli-Calmettes, University Hospital of Montpellier, Cliniques Universitaires Saint-Luc, Inserm, University of Rennes, Centre Virchow-Villermé, University of Liège, Nantes Université, Institut Jules Bordet, Maison des Sciences de l’Homme de Dijon, CHU Dinant Godinne UCL Namur, Centre Hospitalier Universitaire de Clermont-Ferrand, Ziekenhuisnetwerk Antwerpen Stuivenberg, Hôpital Lyon Sud, AZ Sint-Jan
A Phase II LYSA Study of Obinutuzumab Combined with Lenalidomide for Relapsed or Refractory Aggressive B-Cell Lymphoma
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
